Search results
HCPCS codes are used in conjunction with NDC codes for billing and medical documentation puporses. For instance, HCPCS J3420 identifies the type of service or supply used while any of the 37 NDC codes below could be used to specify the exact drug used. Vitamin b12 injection. Injection, vitamin b-12 cyanocobalamin, up to 1000 mcg. Drugs.
- NDC Package 0143-9619-10 Cyanocobalamin
The NDC Packaged Code 0143-9619-10 is assigned to a package...
- NDC Package 0143-9619-10 Cyanocobalamin
The NDC Packaged Code 0517-0031-25 is assigned to a package of 25 vial, multi-dose in 1 tray / 1 ml in 1 vial, multi-dose (0517-0031-01) of Cyanocobalamin, a human prescription drug labeled by American Regent, Inc..
3 paź 2018 · The following ICD-10-CM codes support medical necessity and provide coverage for HCPCS codes: J3420 and J3425. Note:* ICD-10-CM codes T50.995A, T50.995D, and T50.995S apply to administration of Vitamin B 12 as adjunct to Alimta®. All those not listed under the “ICD-10-CM Codes that Support Medical Necessity” section of this article.
The NDC Packaged Code 0143-9619-10 is assigned to a package of 10 vial, multi-dose in 1 box / 30 ml in 1 vial, multi-dose (0143-9619-01) of Cyanocobalamin, a human prescription drug labeled by Hikma Pharmaceuticals Usa Inc..
Drugs are identified and reported using a unique, three-segment number called the National Drug Code (NDC) which serves as the FDA’s identifier for drugs. FDA publishes the listed NDC...
Other CPT codes related to the CPB: 96372: Therapeutic, prophylactic or diagnostic injection (specify substance or drug); subcutaneous or intramuscular: HCPCS codes covered if selection criteria are met: J3420: Injection, vitamin B-12 cyanocobalamin, up to 1000 mcg [covered for intramuscular or subcutaneous use only] J3425: Injection ...
Use the appropriate Healthcare Common Procedure Coding System (HCPCS) based on code descriptor. Not Otherwise Classified (NOC) codes (eg J3490, J3590, J7999) should only be reported for those drugs that do not have a valid HCPCS code which describes the drug being administered or per payer policy.
